• SENSEX 83,021.75
    989.94 (+1.21%)
  • BANKNIFTY 63,063.00
    1,024.35 (+1.65%)
  • NSE
    2,207.00 2,207.00(%)
  • SBI
    1,159.70 1,234.80(%)
  • One 97
    1,664.70 947.10(%)
  • Billionbrains
    218.00 142.05(%)
  • LG Electronics
    1,725.00 1,835.00(%)
  • Bharat Forge
    1,734.40 2,293.00(%)
  • Maruti Suzuki
    13,619.60 17,371.60(%)
  • Reliance Industries
    1,381.95 1,611.20(%)
  • Samvardh. Mothe.
    165.00 173.25(%)
  • Coforge
    2,055.35 2,127.30(%)
  • ICICI Bank
    1,608.75 1,616.70(%)
  • Black Box
    933.85 1,104.30(%)
  • Bharti Airtel
    2,159.95 2,174.70(%)
  • Cipla
    1,406.95 1,165.55(%)
  • M & M
    3,524.50 3,840.00(%)
  • IndusInd Bank
    924.50 1,077.80(%)
  • Max Financial
    1,383.90 1,173.40(%)
  • HDFC Bank
    822.10 1,017.90(%)
  • Tube Investments
    2,247.35 3,335.00(%)
  • Mah. Seamless
    497.00 493.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Amanta Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 23748.0
  • ISIN : INE084K01015
239.08 2 (0.72%)
  • As on 19 Nov 2026 (EOD)
  • Today’s Low

    232.41
  • Today’s High

    241.77
  • Open

    237.35
  • Perv Close

    237.38
  • 52W Low

    92.00
  • 52W High

    245.70

Key Indicators

  • P/E(TTM)

    50.63

  • Mar.Cap (₹Cr.)

    928.33

  • Div & Yield %

    0.00

  • Book Value(₹)

    58.75

  • Debt-Equity Ratio

    0.72

  • AGM Date

    19-Nov-2026

  • EPS

    4.72

  • P/E Ratio

    50.63

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    928.33

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    38.83

  • BV (₹)

    58.80

  • Sales( ₹ in Cr.)

    287.68

  • NP (in Cr.)

    16.37

  • NP Var(%)

    55.0

  • Div%

    0.0

  • CPS (₹)

    9.00

  • EPS (₹)

    4.20

  • Traded Value (₹ in Lakhs)

    927.83

  • 52 Week High

    245.70

  • 52 Week Low

    92.00

  • Price BSE

    239.0

  • Price NSE

    239.00

  • Market Capital( in Cr.)

    927.83

  • P/C Ratio

    26.40

  • P/E Ratio

    56.70

  • Price Vs.BV

    4.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 287.68 274.71 280.34 259.13 225.44 171.29
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 287.68 274.71 280.34 259.13 225.44 171.29
Other Income 3.37 1.39 1.27 3.57 76.09 1.06
Stock Adjustments 10.89 19.53 -17.31 -0.53 12.29 14.32
Total Income 301.94 295.63 264.30 262.17 313.82 186.67
EXPENDITURE :            
Raw Materials 67.89 76.99 52.82 101.24 89.09 63.84
Power and Fuel Cost 22.93 22.23 24.74 23.36 17.85 14.24
Employee Cost 42.96 36.34 32.55 31.87 39.59 34.43
Other Manufacturing Expenses 64.91 60.36 58.93 36.86 24.20 17.98
Selling and Administration Expenses 35.91 34.52 33.41 9.19 9.99 9.51
Miscellaneous Expenses 6.74 4.12 3.10 3.35 4.96 7.28
Employee Benefit Expenses 42.96 36.34 32.55 31.87 39.59 34.43
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 241.34 234.56 205.54 205.87 185.68 147.27
Operating Profit 60.60 61.06 58.76 56.31 128.15 39.40
Interest 20.75 27.95 33.64 35.27 48.88 40.13
Gross Profit 39.85 33.11 25.12 21.04 79.27 -0.73
Depreciation 18.73 18.40 19.73 18.35 17.34 17.02
Profit Before Tax 21.12 14.71 5.39 2.69 61.93 -17.75
Current Tax 8.59 3.59 4.10 -1.28 6.78 3.77
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.34 0.61 -2.35 6.09 0.04 0.31
Reported Net Profit 14.88 10.50 3.63 -2.11 55.11 -21.83
Extraordinary Items -1.49 -0.07 -0.01 0.00 67.84 0.00
Adjusted Net Profit 16.37 10.57 3.64 -2.11 -12.73 -21.83
Adjustment below Net Profit -0.72 -0.40 -0.23 0.00 -2.03 0.00
P & L Balance brought forward 28.56 16.14 10.82 15.00 -40.71 -18.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 10.00 -2.33 -1.91 2.06 0.00 0.00
P & L Balance carried down 32.71 28.56 16.14 10.82 12.37 -40.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.83 3.64 1.35 -0.79 20.54 -8.14
Earnings Per Share(Adj)-Unit Curr 3.83 - - - - -
Book Value 56.71 33.43 24.71 23.44 23.25 2.71
Book Value(Adj)-Unit Curr 56.71 - - - - -

Shareholding Pattern

  • Promoter Group

    63.80%

  • Public Share Holding

    36.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 12,608,808 12,608,808.00 12,608,808 12,608,808
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 12,608,808 32.47 12,608,808 9
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,100,000 7.98 3,100,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,065,302 23.35 9,065,302 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,165,302 31.33 12,165,302 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 25,557 0.07 25,557 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,987,784 5.12 1,987,784 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,748,808 7.08 2,748,808 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,762,149 12.26 4,762,149 10
2] Non Institution
Bodies Corporate 596,528 1.54 596,528 47
Clearing Members 289,423 0.75 289,423 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 497,326 1.28 497,326 84
Foreign Non Institution Other 300,190 0.77 300,190 1
Hindu Undivided Families 486,251 1.25 486,251 309
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,711,447 6.98 2,248,447 54
Individuals holding nominal share capital up to Rs. 1 lakh 4,397,686 11.33 4,116,774 11,785
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,293,092 23.93 8,549,180 12,294
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 38,829,351 100.00 38,060,276 12,319

Company Background

Amanta Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Amanta Healthcare Ltd
  • BSE Code : 23748.0
  • ISIN : INE084K01015
  • Incorporation Year

    1994

  • Registered Office

    8th Floor Shaligram Corporates
    C.J.Marg Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    079 6777 7600

  • FAX

  • Chairman

    Bhavesh Patel

  • Managing Director

    Bhavesh Patel

  • Company Secretary

    Nikhita Dinodia

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Amanta Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Amanta Healthcar 238.95 291.05 287.68 50.63 11.61
Abbott India 25,716.85 7,217.19 6,929.05 33.06 43.78
Astrazeneca Phar 6,120.45 2,304.07 2,275.58 86.09 27.86
Glaxosmi. Pharma 2,714.65 3,932.76 3,790.20 40.34 58.17
Cipla 1,416.00 20,102.60 18,979.95 43.16 13.88
Evonile Pharma 1,394.25 393.10 354.33 -1,223.03 15.94
Bliss GVS Pharma 664.90 773.53 729.81 43.34 12.51
Amrutanjan Healt 516.95 520.13 502.55 26.08 24.16
Fermenta Biotec. 464.40 474.15 450.25 21.95 18.77
Guj. Themis Bio. 358.20 168.25 165.82 108.55 18.05
Ambalal Sarabhai 38.80 19.52 3.94 65.76 6.77